Hangzhou Deshi Biotechnology Co., Ltd. (referred to as 'Deshi', stock code: 2526.HK) has commenced its IPO subscription in Hong Kong, with plans to list on the main board of the Hong Kong Stock Exchange on March 30. The company intends to issue 7,999,200 H shares, with an offering price ranging from HK$95.6 to HK$112.5 per share, and expects to raise up to approximately HK$900 million. Approximately 49% of the funds raised will be used for the research, development, and commercialization of core products, while about 20% will be allocated to strengthen the foundational model and AI technology. After the listing, Deshi is poised to become the 'first stock in medical imaging large models.'
